You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

RETIN-A Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


DrugPatentWatch® Litigation and Generic Entry Outlook for Retin-a

A generic version of RETIN-A was approved as tretinoin by PADAGIS US on December 24th, 1998.

  Subscribe

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for RETIN-A?
  • What are the global sales for RETIN-A?
  • What is Average Wholesale Price for RETIN-A?
Drug patent expirations by year for RETIN-A
Drug Prices for RETIN-A

See drug prices for RETIN-A

Drug Sales Revenue Trends for RETIN-A

See drug sales revenues for RETIN-A

Pharmacology for RETIN-A
Drug ClassRetinoid

US Patents and Regulatory Information for RETIN-A

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bausch RETIN-A tretinoin CREAM;TOPICAL 019049-001 Sep 16, 1988 AB RX Yes Yes ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
Valeant Intl RETIN-A tretinoin SWAB;TOPICAL 016921-002 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
Valeant Intl RETIN-A tretinoin GEL;TOPICAL 017955-001 Approved Prior to Jan 1, 1982 AB RX Yes Yes ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
Bausch RETIN-A MICRO tretinoin GEL;TOPICAL 020475-002 May 10, 2002 RX Yes Yes ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
Valeant Bermuda RETIN-A tretinoin CREAM;TOPICAL 017522-001 Approved Prior to Jan 1, 1982 AB1 RX Yes Yes ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for RETIN-A

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Valeant Intl RETIN-A tretinoin GEL;TOPICAL 017579-002 Approved Prior to Jan 1, 1982 ⤷  Subscribe ⤷  Subscribe
Valeant Pharms North RETIN-A tretinoin CREAM;TOPICAL 017340-001 Approved Prior to Jan 1, 1982 ⤷  Subscribe ⤷  Subscribe
Valeant Intl RETIN-A tretinoin GEL;TOPICAL 017579-002 Approved Prior to Jan 1, 1982 ⤷  Subscribe ⤷  Subscribe
Bausch RETIN-A tretinoin CREAM;TOPICAL 019049-001 Sep 16, 1988 ⤷  Subscribe ⤷  Subscribe
Valeant Intl RETIN-A tretinoin GEL;TOPICAL 017955-001 Approved Prior to Jan 1, 1982 ⤷  Subscribe ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Supplementary Protection Certificates for RETIN-A

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
1304992 SPC/GB13/061 United Kingdom ⤷  Subscribe PRODUCT NAME: CLINDAMYCIN PHOSPHATE IN COMBINATION WITH TRETINOIN.; REGISTERED: IE PA1332/043/001 20130322; UK PL15142/0249 20130624
1304992 2013C/060 Belgium ⤷  Subscribe PRODUCT NAME: CLINDAMYCINE (ALS CLINDAMYCINE FOSFAAT) EN TRETINOINE; AUTHORISATION NUMBER AND DATE: BE437507 20130506
1304992 PA2013025 Lithuania ⤷  Subscribe PRODUCT NAME: CLINFAMYCINUM + TRETINOINUM; REGISTRATION NO/DATE: LT/1/13/3279/001, 2013 04 26 LT/1/13/3279/002, 2013 04 26 PA1332/043/001 20130323
1304992 122013000081 Germany ⤷  Subscribe PRODUCT NAME: CLINDAMYCIN (ALS CLINDAMYCIN-PHOSPHAT) UND TRETINOIN; NAT. REGISTRATION NO/DATE: 85210.00.00 20130611; FIRST REGISTRATION: IRLAND PA1332/043/001 20130322
1304992 1390049-3 Sweden ⤷  Subscribe PRODUCT NAME: KLINDAMYCIN (SOM KLINDAMYCINFOSFAT) OCH TRETINOIN; NAT. REG. NO/DATE: MTNR 46193 20130503; FIRST REG.: IR PA1332/043/001 20130322
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

RETIN-A Market Analysis and Financial Projection Experimental

Market Dynamics and Financial Trajectory for Retin-A (Retinol)

Introduction to Retin-A (Retinol)

Retin-A, commonly known as retinol, is a derivative of vitamin A that has become a cornerstone in the skincare industry. It is widely recognized for its efficacy in addressing various skin concerns such as aging, acne, and hyperpigmentation. Here, we will delve into the market dynamics and financial trajectory of retinol, providing insights into its current state, future projections, and the factors influencing its growth.

Market Size and Growth Projections

The global retinol market has been experiencing steady growth. As of 2023, the market size was valued at approximately USD 1.43 billion and is expected to reach USD 1.87 billion by 2030, growing at a Compound Annual Growth Rate (CAGR) of 3.9%[1][4].

Regional Insights

Europe

Europe dominated the largest share of the retinol market in 2022. The region's stringent regulations and standards for skincare and cosmetic products have driven the emphasis on product safety, quality, and ingredient efficacy. Consumers in Europe are highly aware of the importance of healthy and youthful-looking skin, which has increased the demand for scientifically proven ingredients like retinol[1].

North America

North America is expected to grow at the highest CAGR during the forecast period. The aging population in this region has been a significant driver for the demand in anti-aging skincare products, which includes retinol-based products[1].

Market Drivers

Several factors are driving the growth of the retinol market:

Increasing Awareness of Skincare Benefits

There is a rising awareness among consumers about the health benefits of retinol, particularly its anti-aging properties. This increased awareness has led to a higher demand for skincare products containing retinol[4].

Demand for Anti-Aging Skincare

The global population is aging, and with it, there is a growing demand for anti-aging skincare products. Retinol, with its well-documented benefits in reducing fine lines, wrinkles, and hyperpigmentation, is a key ingredient in many of these products[1][4].

Advancements in Formulation Technology

Advancements in formulation technology have made retinol more stable and effective in various skincare products. This has expanded its application across different product types, including creams, serums, and oils[4].

Clean Beauty and Personalized Skincare Trends

Trends such as clean beauty and personalized skincare are opening new avenues for retinol applications. Consumers are increasingly looking for premium and chemical-free skincare products, which retinol can fulfill[4].

Market Restraints

Despite the growth, there are several challenges facing the retinol market:

Potential Skin Sensitivity Issues

One of the significant restraints is the potential for skin sensitivity issues associated with retinol use. This can deter some consumers from using retinol-based products[4].

Stringent Regulatory Frameworks

The skincare industry is subject to stringent regulatory frameworks, which can be a challenge for manufacturers. Ensuring compliance with these regulations can be costly and time-consuming[1][4].

High Cost of Retinol Products

The high cost of retinol products can be a barrier for price-sensitive consumers, limiting the market's potential growth[4].

Market Opportunities

There are several opportunities that could further drive the growth of the retinol market:

Development of Retinol with Other Active Ingredients

The development of retinol combined with other active ingredients such as stem cells and plant-based topicals presents a significant opportunity. These combinations can enhance the efficacy and appeal of retinol products[4].

Availability on Retail and E-Commerce Portals

The increasing availability of retinol products on retail and e-commerce platforms has made it easier for consumers to access these products, thereby driving demand[4].

Financial Forecasting for Retinol Market

To create a financial forecast for a business involved in the retinol market, several steps can be taken:

Setting Sales Projections

Start by setting a goal for sales. For example, if a company made $1 million in sales in the current year, it might aim to increase sales to $1.5 million in the next year. This increase should be mapped out over the forecast period, typically on a monthly basis[2][5].

Creating Pro Forma Income Statements

Calculate the cost of goods sold and other operating expenses for each month. Deduct these expenses from the projected sales to get the net income. This process helps in creating pro forma income statements that show expected earnings and expenses[2].

Accounting for Expenses

Include all expenses, such as increased marketing or production costs, in the forecast. For instance, if the plan involves quadrupling online advertising, this expense should be reflected in the financial forecast[2].

Adjusting Based on Performance

Regularly review and adjust the financial forecast based on actual performance. If revenue exceeds projections, the budget can be adjusted to reinvest in the business[2].

Example Financial Forecast

Consider a company that produces retinol-based skincare products. Here’s a simplified example:

  • Projected Sales: Increase from $1 million to $1.5 million over the next year.
  • Monthly Sales Increase: $41,667 per month ($500,000 / 12 months).
  • Cost of Goods Sold: 30% of sales.
  • Operating Expenses: $200,000 per year, divided equally across 12 months.

By mapping out these figures, the company can create a detailed financial forecast that helps in planning and decision-making.

Key Takeaways

  • The retinol market is expected to grow at a CAGR of 3.9% from 2023 to 2030.
  • Europe and North America are key regions driving the market growth.
  • Increasing awareness of skincare benefits, demand for anti-aging products, and advancements in formulation technology are major drivers.
  • Potential skin sensitivity issues, stringent regulations, and high product costs are significant restraints.
  • Development of retinol with other active ingredients and increased availability on retail and e-commerce platforms present opportunities for growth.
  • Accurate financial forecasting is crucial for businesses to plan and invest effectively in the retinol market.

FAQs

Q: What is the current market size of the retinol market?

The global retinol market was valued at approximately USD 1.43 billion in 2023[1].

Q: What is the expected CAGR of the retinol market from 2023 to 2030?

The retinol market is expected to grow at a CAGR of 3.9% from 2023 to 2030[1].

Q: Which region dominates the retinol market?

Europe dominated the largest share of the retinol market in 2022 due to stringent regulations and consumer awareness of skincare benefits[1].

Q: What are the main drivers of the retinol market?

The main drivers include increasing awareness of skincare benefits, demand for anti-aging products, and advancements in formulation technology[1][4].

Q: What are some of the challenges facing the retinol market?

Challenges include potential skin sensitivity issues, stringent regulatory frameworks, and the high cost of retinol products[4].

Sources

  1. Maximize Market Research: Retinol Market: Industry Analysis and Forecast (2024-2030)
  2. Bench Accounting: How to Create a Financial Forecast - Bench Accounting
  3. Market Research Intellect: Tretinoin Drugs Industry Market Size, Scope and Forecast Report
  4. Research and Markets: Retinol Market Size, Competitors, Trends & Forecast to 2030
  5. U.S. Chamber of Commerce: How to Write a Financial Forecast for Your Business | CO

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.